Teleflex Incorporated (TFX) : The total money flow in Teleflex Incorporated (TFX) was negative ($7.56 million), which signals selling by the traders on Thursdays session. They trimmed their holdings by selling the stock on downticks to the tune of $16.12 million. In comparison, the inflow of money into the stock on upticks was $8.56 million. The uptick to downtick ratio was 0.53. Similarly, the block trades show selling by large traders on strength. The value of stocks sold down on downtick was $6.06 million. The negative money flow of ($6.06 million) confirms the selling in Teleflex Incorporated (TFX) on strength. Teleflex Incorporated (TFX) gained $1.09 at $179.14, a gain of 0.61% over the previous days close. However, the stock registered -0.01% in the week.
Teleflex Incorporated (TFX) : The consensus price target for Teleflex Incorporated (TFX) is $172.56 for the short term with a standard deviation of $17.17. The most optimist securities analyst among the 9 who monitor the stock believes that the stock can reach $200, however, the pessimist price target for the company is $145. The stock has recorded a 20-day Moving Average of 3.08% and the 50-Day Moving Average is 8.03%.
Teleflex Incorporated (NYSE:TFX): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $177.87 and $177.69 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $180.16. The buying momentum continued till the end and the stock did not give up its gains. It closed at $179.14, notching a gain of 0.61% for the day. The total traded volume was 209,651 . The stock had closed at $178.05 on the previous day.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company also markets and sells its products to hospitals and healthcare providers. The Company operates its business in six segments: Vascular North America; Anesthesia/Respiratory North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company manufactures its products at 26 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. The Companys specialty product line consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology.